136 related articles for article (PubMed ID: 10710505)
1. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations.
Jones CN; Abbasi F; Carantoni M; Polonsky KS; Reaven GM
Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E501-8. PubMed ID: 10710505
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.
Jones CN; Pei D; Staris P; Polonsky KS; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1997 Jun; 82(6):1834-8. PubMed ID: 9177392
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
[TBL] [Abstract][Full Text] [Related]
4. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
5. Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance?
Carantoni M; Abbasi F; Azhar S; Schaaf P; Reaven GM
J Clin Endocrinol Metab; 1999 Mar; 84(3):869-72. PubMed ID: 10084563
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals.
Kim SH; Abbasi F; Chu JW; McLaughlin TL; Lamendola C; Polonsky KS; Reaven GM
Diabetes; 2005 Aug; 54(8):2447-52. PubMed ID: 16046313
[TBL] [Abstract][Full Text] [Related]
7. The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women.
Bützow TL; Lehtovirta M; Siegberg R; Hovatta O; Koistinen R; Seppäla M; Apter D
J Clin Endocrinol Metab; 2000 Sep; 85(9):3271-5. PubMed ID: 10999821
[TBL] [Abstract][Full Text] [Related]
8. Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans.
Carpentier A; Giacca A; Lewis GF
Diabetologia; 2001 Nov; 44(11):1989-97. PubMed ID: 11719829
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.
Polonsky KS; Given BD; Van Cauter E
J Clin Invest; 1988 Feb; 81(2):442-8. PubMed ID: 3276730
[TBL] [Abstract][Full Text] [Related]
10. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G
Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
[TBL] [Abstract][Full Text] [Related]
11. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.
Van Cauter E; Mestrez F; Sturis J; Polonsky KS
Diabetes; 1992 Mar; 41(3):368-77. PubMed ID: 1551497
[TBL] [Abstract][Full Text] [Related]
12. Weight loss-associated changes in acute effects of nateglinide on insulin secretion after glucose loading: results of glucose loading on 2 consecutive days.
Mori Y; Mamori S; Tajima N
Diabetes Obes Metab; 2005 Mar; 7(2):182-8. PubMed ID: 15715891
[TBL] [Abstract][Full Text] [Related]
13. Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance.
Reaven GM; Moore J; Greenfield M
Diabetes; 1983 Jul; 32(7):600-4. PubMed ID: 6345239
[TBL] [Abstract][Full Text] [Related]
14. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
[TBL] [Abstract][Full Text] [Related]
15. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain.
Erdmann J; Kallabis B; Oppel U; Sypchenko O; Wagenpfeil S; Schusdziarra V
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E568-75. PubMed ID: 18171910
[TBL] [Abstract][Full Text] [Related]
16. Effects of muscarinic blockade on insulin secretion and on glucose-induced thermogenesis in lean and obese human subjects.
Schneeberger D; Tappy L; Temler E; Jequier E
Eur J Clin Invest; 1991 Dec; 21(6):608-15. PubMed ID: 1778222
[TBL] [Abstract][Full Text] [Related]
17. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
[TBL] [Abstract][Full Text] [Related]
18. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
19. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
Bonora E; Zavaroni I; Bruschi F; Alpi O; Pezzarossa A; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
J Clin Endocrinol Metab; 1984 Dec; 59(6):1121-7. PubMed ID: 6386838
[TBL] [Abstract][Full Text] [Related]
20. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
Ehrmann DA; Breda E; Cavaghan MK; Bajramovic S; Imperial J; Toffolo G; Cobelli C; Polonsky KS
Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
